|
Volumn 109, Issue 1, 2001, Pages 60-62
|
Gene therapy with sodium/iodide symporter in hepatocarcinoma
|
Author keywords
Gene therapy; Hepatocarcinoma; Sodium iodide symporter (NIS)
|
Indexed keywords
4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID;
ANTIPORTER;
CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE;
IODINE 125;
SODIUM IODIDE;
SODIUM IODIDE SYMPORTER;
SODIUM PERCHLORATE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL MODEL;
ANIMAL TISSUE;
CELL TRANSFER;
DNA MODIFICATION;
DOSE RESPONSE;
DRUG ACCUMULATION;
GENE THERAPY;
GENETIC TRANSDUCTION;
LIVER CELL CARCINOMA;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RAT;
SHORT SURVEY;
THYROID CELL;
4,4'-DIISOTHIOCYANOSTILBENE-2,2'-DISULFONIC ACID;
ANIMALS;
BIOLOGICAL TRANSPORT, ACTIVE;
CARBONYL CYANIDE P-TRIFLUOROMETHOXYPHENYLHYDRAZONE;
DNA METHYLATION;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
HALF-LIFE;
IODIDES;
IODINE;
IODINE RADIOISOTOPES;
LIVER NEOPLASMS, EXPERIMENTAL;
NEOPLASM TRANSPLANTATION;
RATS;
SYMPORTERS;
TRANSCRIPTION, GENETIC;
TUMOR CELLS, CULTURED;
|
EID: 0035122464
PISSN: 09477349
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2001-11010 Document Type: Short Survey |
Times cited : (40)
|
References (19)
|